Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Biomerica Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −2 vs. Q1 2022
- Shares held
- 2.43M
- −93.8K (−3.7%) vs. Q1 2022
- Total value
- $7.01M
- −$4.25M (−37.8%) vs. Q1 2022
- New holders
- 0
- 7 more added
- Sold out
- 2
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Granahan Investment Management Inc | 1,102,993 | $3.19M | 0.11% | −66,848−5.7% | Reduced |
| Vanguard Group Inc | 545,951 | $1.58M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 184,341 | $533.0K | 0.00% | +416+0.2% | Added |
| Fore Capital, LLC | 85,000 | $246.0K | 0.63% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 78,006 | $225.0K | 0.00% | +757+1.0% | Added |
| Heritage Investors Management Corp | 70,350 | $203.0K | 0.01% | +1,000+1.4% | Added |
| Ridgewood Investments LLC | 60,000 | $173.0K | 0.14% | 00.0% | Unchanged |
| State Street Corp | 55,831 | $161.0K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 32,900 | $95.0K | 0.00% | 00.0% | Unchanged |
| Perritt Capital Management Inc | 30,000 | $87.0K | 0.05% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 29,902 | $86.0K | 0.00% | +19,402+184.8% | Added |
| Dimensional Fund Advisors LP | 26,072 | $75.0K | 0.00% | −391−1.5% | Reduced |
| Emerald Advisers, LLC | 19,000 | $55.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 18,148 | $52.0K | 0.00% | +4,486+32.8% | Added |
| Northern Trust Corp | 16,746 | $48.0K | 0.00% | −1,645−8.9% | Reduced |
| Citadel Advisors LLC | 13,457 | $39.0K | 0.00% | −19,353−59.0% | Reduced |
| Group One Trading, L.P. | 11,932 | $34.0K | 0.00% | −15,500−56.5% | Reduced |
| Orion Capital Management LLC | 11,500 | $33.0K | 0.03% | 00.0% | Unchanged |
| HCR Wealth Advisors | 10,000 | $29.0K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 8,605 | $24.0K | 0.00% | −486−5.3% | Reduced |
| Wells Fargo & Company | 6,571 | $19.0K | 0.00% | +5+0.1% | Added |
| Bank of America Corp | 4,032 | $12.0K | 0.00% | −968−19.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,764 | $8.00K | 0.00% | +1,456+111.3% | Added |
| Morgan Stanley | 1,630 | $5.00K | 0.00% | −887−35.2% | Reduced |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Ahrens Investment Partners LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,812−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,415−100.0% | Sold out |